TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

Resource Library

Looking for more information about TAKHZYRO? These materials are a good place to start.

Image of a man playing soccer. Get more information about TAKHZYRO from the Resource Library.

Not an actual patient.

  • TAKHZYRO Brochure

    TAKHZYRO Brochure

    Learn the basics about TAKHZYRO, including how it works to help prevent HAE attacks.

    Download
  • TAKHZYRO Instructions for Use.

    Instructions for Use Brochure

    Find out more about how to self-administer TAKHZYRO.

    Download
  • TAKHZYRO Discussion Guide and FAQs

    Discussion Guide and FAQs Brochure

    Get helpful tips for starting the conversation about TAKHZYRO with your healthcare provider.

    Download
  • Travel Medical Letter

    Print this form and have your healthcare provider fill it out so that you are always prepared to travel with TAKHZYRO.

    Download

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.